The Patent Finder

Armo Biosciences, Inc.

Also on record
Records under this name other than the patents Armo Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Showing 1 to 6 of 6 · Back to Armo Biosciences, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,814,679Interleukin-10 Production of Antigen-Specific CD8+ T Cells and Methods of Use of Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,413,332Methods of Using Interleukin-10 for Treating Diseases and Disorders
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,350,270Interleukin-15 compositions and uses thereof
Lapsed on the fee record
Ended Jul 16, 2023 · USPTO record
Lapsed on the fee recordEnded Jul 16, 2023USPTO record
US 10,010,588Methods of using pegylated interleukin-10 for treating hyperlipidemia
Lapsed on the fee record
Ended Jul 3, 2022 · USPTO record
Lapsed on the fee recordEnded Jul 3, 2022USPTO record
US 6,387,364Methods of healing wounds and fibrotic disorders using IL-10
Term ended
Term ended May 1, 2020 · USPTO record
Term endedTerm ended May 1, 2020USPTO record
US 7,052,684Methods of healing wounds and fibrotic disorders using IL-10
Lapsed on the fee record
Ended May 30, 2018 · USPTO record
Lapsed on the fee recordEnded May 30, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited